FENLAND GROUP PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: D81611 | MARCH, PE15 0GN
Showing results 601-650 of 680
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fusidic acid | 14 | 70 | £305 | +35.5% ▲ |
| Hepatitis B | 14 | 14 | £229 | +32.3% ▲ |
| 14 | 37 | £989 | +1.4% vs avg | |
| 14 | 1,030 | £245 | -55.9% ▼ | |
| 14 | 390 | £1.6K | +19.2% ▲ | |
| Phosphates (Rectal) | 13 | 283 | £1.1K | +6.4% ▲ |
| Dronedarone hydrochloride | 13 | 780 | £776 | -10.0% ▼ |
| Celiprolol hydrochloride | 13 | 364 | £295 | -1.7% vs avg |
| Terazosin hydrochloride | 13 | 364 | £67 | -20.1% ▼ |
| Eprosartan | 13 | 304 | £138 | -35.6% ▼ |
| Gemfibrozil | 13 | 728 | £411 | +28.7% ▲ |
| Trifluoperazine | 13 | 1,102 | £520 | -13.8% ▼ |
| Lofepramine hydrochloride | 13 | 1,092 | £413 | -56.5% ▼ |
| Guanfacine | 13 | 344 | £724 | -49.4% ▼ |
| Eletriptan | 13 | 84 | £283 | +31.7% ▲ |
| Ethosuximide | 13 | 6,150 | £4.8K | -11.9% ▼ |
| Entacapone | 13 | 1,560 | £350 | -14.7% ▼ |
| Saxagliptin | 13 | 364 | £390 | -61.1% ▼ |
| Magnesium glycerophosphate | 13 | 518 | £185 | -5.4% ▼ |
| Powder delisted probiotic (0913531) | 13 | 1,560 | £2.0K | +90.3% ▲ |
| Tube feed 1.3kcal/ml with fibre, higher protein (0914011) | 13 | 330.0K | £5.8K | +25.5% ▲ |
| Diethylamine salicylate | 13 | 1,300 | £38 | -51.8% ▼ |
| Acetic acid | 13 | 65 | £59 | +12.2% ▲ |
| Chlorhexidine gluconate | 13 | 7,800 | £54 | -40.8% ▼ |
| Dimeticone (Barrier) | 13 | 6,500 | £58 | -11.6% ▼ |
| 13 | 2,100 | £20 | -48.3% ▼ | |
| 13 | 580 | £425 | -2.1% ▼ | |
| 13 | 295 | £762 | -30.4% ▼ | |
| Perindopril arginine with diuretic | 12 | 360 | £101 | -8.6% ▼ |
| Telmisartan | 12 | 336 | £134 | -79.3% ▼ |
| Loprazolam mesilate | 12 | 672 | £526 | -9.3% ▼ |
| Oxazepam | 12 | 1,029 | £135 | -43.7% ▼ |
| Modafinil | 12 | 360 | £24 | -42.4% ▼ |
| Aspirin | 12 | 339 | £58 | +22.1% ▲ |
| Mercaptopurine | 12 | 387 | £197 | -22.5% ▼ |
| Degarelix | 12 | 12 | £1.2K | -30.9% ▼ |
| Tube feed non ACBS 1kcal/ml higher protein (0914061) | 12 | 240.5K | £6.9K | +183.8% ▲ |
| Heparinoid | 12 | 1,500 | £77 | -54.2% ▼ |
| Tars | 12 | 2,975 | £167 | +43.2% ▲ |
| Cocois | 12 | 1,200 | £170 | -12.6% ▼ |
| Ketoconazole | 12 | 390 | £50 | +20.6% ▲ |
| Aciclovir | 12 | 54 | £52 | -2.7% ▼ |
| 12 | 24 | £49 | +122.7% ▲ | |
| 12 | 1,675 | £2.1K | +44.6% ▲ | |
| 12 | 360 | £34 | -55.3% ▼ | |
| Minoxidil | 11 | 330 | £43 | -1.3% vs avg |
| Methyldopa | 11 | 1,764 | £432 | -35.4% ▼ |
| Dabigatran etexilate | 11 | 471 | £356 | -78.8% ▼ |
| Omega-3-acid ethyl esters | 11 | 588 | £268 | -47.9% ▼ |
| Salbutamol | 11 | 530 | £189 | +63.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.